These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10395282)

  • 21. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
    Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
    J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-affinity NMDA receptor antagonists. The neuroprotective potential of ARL 15896AR.
    Palmer GC; Miller JA; Cregan EF; Gendron P; Peeling J
    Ann N Y Acad Sci; 1997 Oct; 825():220-31. PubMed ID: 9369989
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
    Sozio P; Cerasa LS; Laserra S; Cacciatore I; Cornacchia C; Di Filippo ES; Fulle S; Fontana A; Di Crescenzo A; Grilli M; Marchi M; Di Stefano A
    Eur J Pharm Sci; 2013 May; 49(2):187-98. PubMed ID: 23454012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CoMFA and homology-based models of the glycine binding site of N-methyl-d-aspartate receptor.
    Tikhonova IG; Baskin II; Palyulin VA; Zefirov NS
    J Med Chem; 2003 Apr; 46(9):1609-16. PubMed ID: 12699379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future of neuroprotective drugs in doubt.
    Birmingham K
    Nat Med; 2002 Jan; 8(1):5. PubMed ID: 11786882
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
    J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, preliminary evaluation and molecular modeling studies of new, conformationally constrained analogues of the competitive NMDA receptor antagonist 4-(phosphonomethyl)-2-piperidinecarboxylic acid (CGS 19755).
    Pellicciari R; Marinozzi M; Natalini B; Costantino G; Lankin DC; Snyder JP; Monahan JB
    Farmaco; 1997; 52(6-7):477-86. PubMed ID: 9490080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Baudy RB; Fletcher H; Yardley JP; Zaleska MM; Bramlett DR; Tasse RP; Kowal DM; Katz AH; Moyer JA; Abou-Gharbia M
    J Med Chem; 2001 May; 44(10):1516-29. PubMed ID: 11334562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).
    Sun L; Chiu D; Kowal D; Simon R; Smeyne M; Zukin RS; Olney J; Baudy R; Lin S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):563-70. PubMed ID: 15075380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
    J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues.
    Kornberg BE; Nikam SS; Wright JL; Kesten SR; Meltzer LT; Coughenour L; Barr B; Serpa KA; McCormick J
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1213-6. PubMed ID: 14980668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site.
    Kroemer RT; Koutsilieri E; Hecht P; Liedl KR; Riederer P; Kornhuber J
    J Med Chem; 1998 Jan; 41(3):393-400. PubMed ID: 9464369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral cortical muscarinic cholinergic and N-methyl-D-aspartate receptors mediate increase in cortical blood flow elicited by chemical stimulation of periaqueductal gray matter.
    Nakai M; Maeda M
    Neuroscience; 2000; 98(3):449-57. PubMed ID: 10869839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of argiotoxin 636 and analogues: selective antagonists for ionotropic glutamate receptors.
    Nelson JK; Frølund SU; Tikhonov DB; Kristensen AS; Strømgaard K
    Angew Chem Int Ed Engl; 2009; 48(17):3087-91. PubMed ID: 19152392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of inhibiting N-methyl-D-aspartate receptors, P2X receptors and the mitogen-activated protein kinase cascade: a quantitative analysis in organotypical hippocampal slice cultures subjected to oxygen and glucose deprivation.
    Rundén-Pran E; Tansø R; Haug FM; Ottersen OP; Ring A
    Neuroscience; 2005; 136(3):795-810. PubMed ID: 16344152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
    Smith PF
    Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists.
    Bigge CF
    Biochem Pharmacol; 1993 Apr; 45(8):1547-61. PubMed ID: 7683469
    [No Abstract]   [Full Text] [Related]  

  • 40. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.
    Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K
    J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.